Bulk Pharmaceutical API Sources for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Bulk Pharmaceutical API Sources for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		23667300
MolPort		MolPort-003-666-398
Hangzhou APIChem Technology		AC-1303
NIH Clinical Collection		SAM002564251
ABBLIS Chemicals		AB1009432

Bulk Active Pharmaceutical Ingredient (API) Sources for: MEFOXIN in Dextrose 5% in Plastic Container

Last updated: August 8, 2025

Introduction

The pharmaceutical industry relies heavily on the consistent and reliable sourcing of Active Pharmaceutical Ingredients (APIs) to ensure medication safety, efficacy, and regulatory compliance. MEFOXIN, the brand name for cefoxitin sodium, a broad-spectrum cephalosporin antibiotic, frequently appears in intravenous formulations such as Dextrose 5% in Plastic Container (Dextrose 5% in PVC bags). Securing bulk API sources for cefoxitin sodium is paramount for pharmaceutical manufacturers aiming to produce high-quality, compliant formulations at scale.

Understanding MEFOXIN and Its API

Cefoxitin Sodium, the API in MEFOXIN, is a hydrolysis-resistant cephamycin antibiotic effective against a range of bacterial infections. Its stability and solubility in aqueous solutions make it suitable for injectable forms like Dextrose 5% solutions. Given the criticality of such formulations, sourcing high-grade cefoxitin sodium API from reputable suppliers is essential to meet stringent pharmaceutical standards, including those set by USP, EP, JP, and other regulatory bodies.

Global API Manufacturers of Cefoxitin Sodium

The drug's API is synthesized primarily by large-scale chemical manufacturers specializing in cephalosporin antibiotics. China's pharmaceutical industry accounts for a significant share of API production, complemented by manufacturers in India, Europe, and the United States. Each supplier's reputation hinges on quality control, compliance with Good Manufacturing Practices (GMP), and reliable supply chains.

Leading API Suppliers for Cefoxitin Sodium

1. Wockhardt Ltd. (India)

Wockhardt, a leading Indian pharmaceutical firm, manufactures cephalosporin APIs, including cefoxitin sodium, with GMP certification aligned with WHO standards. The company's extensive manufacturing capabilities and strategic API export experience position it as a reputable source [1].

2. Fosun Pharma (China)

Fosun Pharma's API division produces a broad portfolio, notably including cephalosporin APIs like cefoxitin sodium. Their facilities adhere to international quality standards, and Fosun's integration among global supply chains makes their APIs a dependable option [2].

3. Zhejiang Hisun Pharmaceuticals (China)

Specialized in antibiotic APIs, Zhejiang Hisun Pharmaceuticals offers cefoxitin sodium for global export markets. Their robust manufacturing infrastructure and compliance with international standards support high-quality API supply [3].

4. Sandoz (Novartis) / Hexal (Germany)

Sandoz, a division of Novartis, has a well-established API manufacturing arm providing cephalosporin APIs, including cefoxitin sodium, to the pharmaceutical industry. Their APIs are manufacturing under strict GMP guidelines, ensuring product reliability [4].

5. AmbioPharma Inc. (USA)

AmbioPharma supplies cephalosporin APIs, including cefoxitin sodium, with an emphasis on North American markets. Their facilities are inspected and certified for GMP and ISO standards, offering high-purity APIs suitable for parenteral formulations [5].

Key Considerations for API Sourcing

• Quality and Compliance: Ensure suppliers have current GMP certification and conform to USP, EP, or other relevant pharmacopeial standards.
• Purity and Stability: Verify API specifications regarding assay purity, residual solvents, heavy metals, and stability profiles.
• Regulatory Approvals: Preference for suppliers with DMF (Drug Master Files) or API registrations with major regulators (FDA, EMA, PMDA).
• Supply Chain Reliability: Assess the supplier’s capacity for consistent volume production and delivery timelines.
• Cost-effectiveness: Balance price points with quality standards to optimize manufacturing margins without compromising quality.

Regional API Sources and Considerations

• India: Known for cost-effective, high-volume API manufacturing, Indian firms like Wockhardt and Aurobindo Pharma serve as primary sources for cefoxitin sodium.

• China: Offers large-scale manufacturing, often at lower costs, with companies like Fosun Pharma and Hisun producing APIs meeting international standards. Due diligence on quality certifications is critical when sourcing from China.

• Europe & USA: Suppliers like Sandoz and AmbioPharma provide high-quality APIs, often with advanced regulatory documentation, suitable for markets with strict compliance requirements, albeit at higher costs.

Regulatory and Quality Assurance

API suppliers must demonstrate adherence to quality systems, including batch validation, stability testing, and comprehensive documentation. Transparency with regulatory bodies is crucial, especially for APIs used in injectable formulations, due to the high safety standards.

In addition, selecting suppliers with prior FDA or EMA inspections can streamline registration processes and reduce regulatory hurdles. Outsourcing to suppliers possessing extensive pharmacopoeial certification simplifies the validation process in different jurisdictions.

Supply Chain and Strategic Sourcing

In the dynamic landscape of pharmaceutical manufacturing, fostering strategic supplier relationships enhances supply reliability. Multi-sourcing strategies can mitigate risks associated with geopolitical tensions, logistical disruptions, or regulatory changes.

Moreover, establishing long-term agreements with key API producers provides advantages such as volume discounts, prioritized supply, and collaborative quality improvements.

Challenges in API Sourcing for Cefoxitin Sodium

• Quality Variability: Differing standards across regions necessitate rigorous qualification programs.
• Regulatory Barriers: Stringent documentation requirements can delay procurement and validation.
• Price Fluctuations: Fluctuations in raw material costs affect API pricing.
• Intellectual Property Risks: Ensuring genuine APIs and avoiding counterfeit products is critical, especially from lesser-known suppliers.

Conclusion

Securing a reliable, high-quality bulk API source for cefoxitin sodium—specifically for MEFOXIN in Dextrose 5%—requires comprehensive due diligence, aligning with regulatory standards, and establishing strategic partnerships with reputable manufacturers. Indian, Chinese, North American, and European suppliers each offer unique advantages, with choices contingent on quality, cost, regulatory acceptance, and supply stability. Successful sourcing ensures that pharmaceutical manufacturers can produce safe, efficacious, and compliant MEFOXIN formulations to meet global demand.

---

Key Takeaways

• Start with established, GMP-certified suppliers such as Wockhardt, Fosun Pharma, or AmbioPharma for dependable cefoxitin sodium API.
• Prioritize suppliers with active regulatory filings, comprehensive documentation, and proven international compliance.
• Balance cost considerations with quality standards to optimize profitability and product safety.
• Develop multi-source procurement strategies to mitigate supply chain disruptions.
• Conduct ongoing quality audits and validation to maintain product integrity over long-term partnerships.

---

FAQs

1. What are the primary regions for sourcing cefoxitin sodium API?
India, China, Europe, and North America are key regions, with India and China leading in volume and cost-efficiency, and Europe and North America providing high-grade APIs with strict regulatory compliance.

2. How can pharmaceutical companies verify the quality of API suppliers?
By reviewing GMP certifications, inspection reports, pharmacopoeial compliance, and requesting samples for testing and validation, companies can assess API quality.

3. What factors influence the choice between low-cost and premium API suppliers?
Regulatory compliance, quality assurance, supply stability, and cost must be balanced; premium suppliers often provide higher assurance of consistent quality and regulatory acceptability.

4. Are Chinese API manufacturers suitable for producing APIs for injectable drugs?
Yes, many Chinese manufacturers produce APIs under GMP standards compliant with major international guidelines; due diligence is critical to confirm quality and compliance.

5. How important is regulatory approval documentation for API sourcing?
Crucial—regulatory documentation such as DMFs, batch records, and registration certificates facilitate market approval and streamline compliance verification.

---

Sources:

[1] Wockhardt Ltd. Official Website.

[2] Fosun Pharma API Portfolio.

[3] Zhejiang Hisun Pharmaceuticals API Specifications.

[4] Sandoz API Capabilities.

[5] AmbioPharma Inc. API Manufacturing Standards.